At the RNA level, ZnT1, ZnT9 and ZnT10 were significantly upregulated in human prostate cancer tissues compared to those in adjacent normal tissues, implying that intracellular zinc is diminished through this upregulation of zinc output transporters [110]. Here, SLC30A1 is linked to prostate carcinoma.